Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunomodulatory functions of the circ_001678/miRNA-326/ZEB1 axis in non-small cell lung cancer via the regulation of PD-1/PD-L1 pathway
Qi Tian, Tong Wu, Xiudi Zhang, et al.
Human Molecular Genetics (2022) Vol. 31, Iss. 23, pp. 4094-4106
Closed Access | Times Cited: 20

Showing 20 citing articles:

Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks
Lingjiao Meng, Haotian Wu, Jiaxiang Wu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Regulation of the tumor immune microenvironment by cancer-derived circular RNAs
Liping Guan, Qian Hao, Fenfen Shi, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 27
The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications
Yu Ma, Ting Wang, Xudong Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 15
Circular RNAs in tumor immunity and immunotherapy
Wenjie Zhang, Xu Chen, Zhipeng Yang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy
Rui Han, Xiwu Rao, Huiling Zhou, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4803-4834
Open Access | Times Cited: 8
Circular RNAs: key players in tumor immune evasion
Mahla Sanati, Soudeh Ghafouri‐Fard
Molecular and Cellular Biochemistry (2025)
Closed Access
Theoretical perspectives and clinical applications of non-coding RNA in lung cancer metastasis: a systematic review
Jie Yang, Yixin Luo, Zuhuan Yao, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Hsa_circ_0000515 sequesters microRNA‐296‐5p and elevates RNF44 expression to encourage the NSCLC progression
Lixin Sun, Bei Lü, Chongyuan Li, et al.
Journal of Cell Communication and Signaling (2025) Vol. 19, Iss. 1
Open Access
Single-cell and spatial transcriptomics reveal correlation between RNA methylation-related miRNA risk model and immune infiltration in hepatocellular carcinoma
Rong Su, Yong Du, Pan Tian, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1
Yanbin Zhang, Daoxin Ma, Xiaojuan Zhang, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access
Circular RNAs in lung cancer: implications for preventing therapeutic resistance
Wenjuan Liu, Yawen Sun, Yanfei Huo, et al.
EBioMedicine (2024) Vol. 107, pp. 105309-105309
Open Access | Times Cited: 2
CircSCUBE3 Reduces the Anti-gastric Cancer Activity of Anti-PD-L1
Hu-Sheng Shan, Xiaobo Zhang, Xiao Zhang, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 1, pp. 123-137
Closed Access | Times Cited: 5
Roles of circRNA dysregulation in esophageal squamous cell carcinoma tumor microenvironment
Jingyi Li, Song Yu-xia, Huihong Cai, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway
Gui‐Lin Jin, Mi Ma, Chunyan Yang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 24, pp. 2493-2503
Open Access | Times Cited: 4
CircRNAs: A Promising Star for Treatment and Prognosis in Oral Squamous Cell Carcinoma
Mengyi Zhu, Daoyang Chen, Chuangdong Ruan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14194-14194
Open Access | Times Cited: 4
circRNF10 Regulates Tumorigenic Properties and Natural Killer Cell-Mediated Cytotoxicity against Breast Cancer through the miR-934/PTEN/PI3k-Akt Axis
Fei Liu, Yang Sang, Yang Zheng, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5862-5862
Open Access | Times Cited: 6
The Interaction of Programmed Cell Death Protein and Its Ligands with Non-Coding RNAs in Neoplasms: Emerging Anticancer Immunotherapeutics
Mahmoud Kandeel, Duaa Althumairy, Ibrahim M. El-Sabagh, et al.
Processes (2023) Vol. 11, Iss. 2, pp. 538-538
Open Access | Times Cited: 1
Non-coding RNAs in cancer immunotherapy: A solution to overcome immune resistance?
Fatemeh Afra, Seyed Parsa Eftekhar, Amir Salehi Farid, et al.
Progress in molecular biology and translational science (2024), pp. 215-240
Closed Access
Immunomodulatory behavior of CircRNAs in tumor microenvironment
H. Liang, Wei Yan, Zhi Liu, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024), pp. 1-10
Closed Access
Circ-PGAM1 Enhances Matrine Resistance of Non-Small Cell Lung Cancer via the miR-326/CXCR5 Axis
Caijun Dong, Liangwei Yang, Guofang Zhao
Cancer Biotherapy and Radiopharmaceuticals (2022) Vol. 39, Iss. 8, pp. 593-599
Closed Access | Times Cited: 2
Downregulation ofmicroRNA‐326 enhancesZNF322Aexpression, transcriptional activity and tumorigenic effects in lung cancer
Shih‐Hsuan Huang, Hung‐Chia Hsieh, Jiunn‐Min Shieh, et al.
BioFactors (2023) Vol. 50, Iss. 1, pp. 214-227
Closed Access
Page 1

Scroll to top